2024-09-02 - Analysis Report
## CVS Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management services, and healthcare services.

**1. Performance Comparison:**

CVS has underperformed the S&P 500 significantly, with a cumulative return of -17.37% compared to the S&P 500's 89.66%. This represents a substantial divergence, with a relative divergence of -107.03, indicating that CVS has lagged the market significantly during the period analyzed.

**2. Recent Price Action:**

CVS's recent price action suggests a slight downward trend:

* **Closing Price:** 57.24
* **5-day Moving Average:** 57.52
* **20-day Moving Average:** 57.56
* **60-day Moving Average:** 58.95

**3. Technical Indicators:**

* **RSI:** 59.78, indicating a neutral market sentiment.
* **PPO:** -0.05, indicating a slight bearish bias.
* **Delta_Previous_Relative_Divergence:** -11.1, suggesting a recent decline in relative divergence, potentially signaling a potential shift in the performance trend.
* **Expected_Return:** 12.6%, indicating a potential for a 12.6% return over the next five years.

**4. Recent Earnings and Outlook:**

CVS's recent earnings have been mixed:

| Date       | EPS     | Expected EPS |
|-------------|---------|---------------|
| 2024-08-07 | 1.83    | 1.73          |
| 2024-05-01 | 1.31    | 1.7           |
| 2024-02-07 | 2.12    | 2.01          |
| 2023-11-01 | 2.21    | 2.13          |
| 2023-08-02 | 2.21    | 2.12          |

The most recent earnings report (2024-08-07) showed a positive beat, exceeding analysts' expectations. However, the previous few quarters have seen some misses, indicating volatility in the company's earnings performance.

**5. Overall Analysis:**

CVS has significantly underperformed the broader market, with its performance lagging the S&P 500 considerably. While recent earnings have shown some positive signs, its overall performance remains a concern. The technical indicators suggest a neutral market sentiment and a slight bearish bias, indicating caution. However, the potential for a 12.6% return over the next five years remains positive. Further research and analysis are necessary to assess the risk and potential reward associated with investing in CVS. 

**6. Conclusion:**

CVS faces challenges in its competitive market, and its past performance has been disappointing compared to the broader market. While its recent earnings beat is a positive sign, ongoing scrutiny of the company's operational efficiency and future growth potential is essential before making an investment decision.
